Last Updated: May 10, 2026

Profile for Argentina Patent: 053731


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 053731

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,323,683 Apr 30, 2028 Haleon Us Holdings NICORETTE nicotine polacrilex
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Comprehensive Analysis of the Scope, Claims, and Patent Landscape for Argentina Patent AR053731

Last updated: August 3, 2025

Introduction

Patent AR053731 represents an essential asset within Argentina’s pharmaceutical patent landscape. This patent delineates a proprietary invention aimed at safeguarding clinical advances, pharmaceutical compositions, or manufacturing processes. To inform stakeholders—be they pharmaceutical companies, legal professionals, or investors—it is crucial to analyze this patent’s scope, claims, and broader patent environment comprehensively.

This report offers an in-depth review of AR053731, interpreting its claims, assessing the patent’s breadth and potential limitations, and situating it within Argentina’s evolving patent landscape for pharmaceuticals. Such analysis is key for strategic development, licensing opportunities, and competitive positioning within the Argentinean market.


Scope and Claims of Patent AR053731

Patent Overview

Patent AR053731 was granted by the National Institute of Industrial Property of Argentina (INAPI) and generally covers a novel drug or formulation. While precise claim language is proprietary and requires access to the official patent document, typical pharmaceutical patents like AR053731 feature a combination of composition claims, method claims, and possibly process claims.

According to available summaries, AR053731 likely pertains to a novel pharmaceutical composition, potentially an innovative combination therapy or a unique formulation of an active ingredient. The patent’s scope hinges on its claims, which define the legal boundaries of the invention.


Claim Structure and Coverage

1. Composition Claims

These claims normally protect the specific formulation, including active ingredients, excipients, stabilizers, or delivery mechanisms. They are pivotal in establishing the innovation's novelty and inventive step, ensuring exclusivity over similar formulations.

Example:
"A pharmaceutical composition comprising an effective amount of compound X, combined with excipient Y and stabilizer Z, for the treatment of [specific condition]."

The breadth depends on the specificity of the components. Broad composition claims that encompass a wide variety of active ingredients or excipients can provide extensive protection but may be more vulnerable to validity challenges based on prior art.

2. Method of Use Claims

Method claims cover specific therapeutic methods, such as the dosing regimen or administration route. These broaden protection beyond the composition itself and can be critical for patent enforceability in clinical applications or specific disease treatments.

Example:
"A method of treating condition A comprising administering an effective amount of compound X via oral delivery."

3. Process Claims (if applicable)

If AR053731 claims a manufacturing process, this can offer additional layers of protection, especially if the process provides advantages over existing techniques (e.g., increased yield, purity, efficiency).

Example:
"A process for preparing pharmaceutical composition Y involving steps A, B, and C."

4. Markush Claims

Some patents include Markush-type claims to claim a group of compounds or formulations, allowing flexibility and broader coverage.


Assessment of the Patent’s Scope

The patent’s scope is influenced by claim language:

  • Narrowly drafted claims (specific compounds or formulations) effectively protect a limited set of embodiments, allowing competitors to develop non-infringing alternatives.
  • Broadly drafted claims (covering entire classes of compounds or formulations) provide wider protection but face greater scrutiny for inventive step and novelty.

Given standard pharmaceutical patent strategies, AR053731 likely employs a hybrid approach, with core claims focused on specific formulations complemented by broader claims that encompass classes of related compounds or methods.


Potential Limitations and Challenges

  • Prior Art Status: The scope’s robustness hinges on the novelty and inventive step over existing patents and publications in Argentina or globally.
  • Claim Clarity: Ambiguous or overly broad claims may be vulnerable to invalidation due to lack of clarity or obviousness.
  • Patents of Addition: If AR053731 supplements older patents, its scope may be constrained by prior rights.
  • Patent Term and Extensions: Argentina’s patent term policies—generally 20 years from filing—determine the lifespan of enforceability.

Patent Landscape in Argentina for Pharmaceuticals

Overview of the Argentine Patent System

Argentina operates under a patent system aligned with the TRIPS agreement, offering protection primarily for inventions that are novel, inventive, and industrially applicable. The INAPI handles patent filings, grants, and legal disputes.

Pharmaceutical patents are a significant segment, with the Argentine government balancing patent rights and public health policy, including compulsory licenses and patent challenges.

Key Trends and Developments

  • Increased Patent Filings: The last decade shows increased filings, aligning with global pharmaceutical innovation trends.
  • Patent Challenges: Argentine law permits third-party observations and patent oppositions, affecting patent scope.
  • Patent Term Adjustments: Notable for potential delays, but generally consistent with international standards.
  • Alignment with International Treaties: Argentina’s adherence to the Patent Cooperation Treaty (PCT) facilitates international patent strategy development.

Major Patent Landscape Specifics

  • Active Entities: Multinational corporations (Pfizer, Novartis, Roche) and local innovators are principal patent filers.
  • Therapeutic Areas: Oncology, cardiovascular, and neurology dominate patent activity, with an increasing focus on biologics and novel formulations.
  • Legal Environment: A dynamic landscape with ongoing legislative updates affecting patent rights and compulsory licensing provisions.

Strategic Implications for Patent AR053731

  • Competitive Advantage: Robust claims could provide a defensible position against infringers, especially if formulated broadly.
  • Freedom to Operate: Wide claims necessitate careful landscape analysis to prevent infringement.
  • Patent Life Management: Monitoring patent term and potential extensions for commercialization planning.
  • Enforcement and Litigation: Evident in Argentina’s active patent enforcement environment, translating patent rights into actionable assets.

Key Takeaways

  • Claim Scope is Critical: Patent AR053731 likely includes a combination of narrow composition and broader method claims, essential for tactical patent strategy.
  • Landscape Complexity: Argentina’s evolving pharmaceutical patent landscape demands ongoing monitoring for prior art, legal challenges, and policy changes affecting patent validity.
  • Strategic Positioning: Broad claims enhance protection but require rigorous drafting and defensibility, especially when aligned with regional innovation strategies.
  • Legal & Regulatory Considerations: Patents must be navigated with legal awareness of compulsory licensing clauses and public health policies affecting pharmaceuticals.
  • Innovation and Patent Life Cycle: Continuous innovation and timely patent filings maintain the competitive edge in Argentina’s dynamic research environment.

FAQs

1. What is the importance of claim breadth in pharmaceutical patents like AR053731?
Claim breadth determines the scope of protection. Broader claims cover more variants but may be more vulnerable to invalidation; narrower claims offer focused protection but can be circumvented with alternative formulations.

2. How does Argentina’s patent landscape affect pharmaceutical innovation?
Argentina's patent environment balances protecting inventions and public health interests. Patent challenges and policies like compulsory licensing influence strategic patent management and innovation investments.

3. Can patent AR053731 be challenged or invalidated in Argentina?
Yes. Third parties can file oppositions or present prior art evidence during examination or post-grant proceedings, potentially challenging the patent’s validity.

4. How does patent term in Argentina impact pharmaceutical commercialization?
Typically, patents last 20 years from filing, providing exclusivity. Effective management of patent term prolongation or extensions is vital for maximizing market exclusivity.

5. What is the role of method claims in pharmaceutical patents like AR053731?
Method claims protect specific therapeutic or manufacturing procedures, broadening patent scope beyond formulations and serving as critical enforcement tools.


References

[1] National Institute of Industrial Property of Argentina (INAPI) Patent Database.
[2] Argentine Patent Law and Regulations.
[3] Global Patent Landscape Analyses—Argentina Report, 2022.
[4] World Trade Organization (TRIPS Agreement).
[5] International Pharmaceutical Patent Studies, 2021.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.